Yalta, KenanYetkin, ErtanYalta, Tulin2024-06-122024-06-1220211122-06432532-5264https://doi.org/10.4081/monaldi.2021.1718https://hdl.handle.net/20.500.14551/24155Over recent decades, systemic inflammation as quantified with inflammation markers or indices has been extensively investigated in the setting of various cardiovascular conditions including heart failure (HF), acute coronary syndromes (ACS). In contrast, systemic inflammation in patients with takotsubo syndrome (TTS) has been an underrated phenomenon in clinical practice. On the other hand, experimental and clinical data have been rapidly growing in the recent years regarding pathogenetic, prognostic as well as therapeutic implications of systemic inflammation in TTS. Accordingly, the present article aims to provide a general perspective on mechanistic and clinical aspects of systemic inflammation in the setting of TTS.en10.4081/monaldi.2021.1718info:eu-repo/semantics/openAccessTakotsubo SyndromeSystemic InflammationInflammation MarkersInflammation IndicesMechanismsClinical Implications.ContributionTako-Tsubo CardiomyopathyCoronary Slow FlowRheumatoid-ArthritisArrhythmogenesisPrevalencePrognosisRecoveryIntervalCancerReview Article912N/AWOS:0006560442000072-s2.0-8510614428133728882Q3